Up Next
Back to Show
PBS News Hour
FDA criticized for Alzheimer's drug approval process
New findings from a congressional investigation into the Food and Drug Administration and the biotech company Biogen find the FDA broke its own protocols to approve a new Alzheimer’s drug last year. The report said the FDA worked too closely with Biogen despite significant concerns over the limited benefits and side effects of the new drug, Aduhelm. Geoff Bennett reports.
Sign up now for inspiring and thought-provoking media delivered straight to your inbox.
Support Provided By
56:44
June 20, 2025 - PBS News Hour full episode
57:46
June 19, 2025 - PBS News Hour full episode
57:46
June 18, 2025 - PBS News Hour full episode
57:46
June 17, 2025 - PBS News Hour full episode
57:46
June 16, 2025 - PBS News Hour full episode
26:45
June 15, 2025 - PBS News Weekend full episode
26:45
June 14, 2025 - PBS News Weekend full episode
57:46
June 13, 2025 - PBS News Hour full episode
57:46
June 12, 2025 - PBS News Hour full episode
57:46
June 11, 2025 - PBS News Hour full episode
57:46
June 10, 2025 - PBS News Hour full episode
56:45
June 9, 2025 - PBS News Hour full episode